Oxford Nanopore Technologies PLC
Company Profile
Business description
Oxford Nanopore Technologies PLC makes a novel generation of DNA/RNA sequencing technology that provides rich data and is fast, accessible, and easy to use. The company is predominantly involved in researching, developing, manufacturing, and commercializing a nanopore-based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA). This enables its customers to perform scientific/biomedical research in a range of areas, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science. The company's reportable segments are; Life Science Research Tools which generates key revenue, and COVID Testing.
Contact
Edmund Halley Road
Gosling Building, Oxford Science Park
OxfordOxfordshireOX4 4DQ
GBRT: +44 8450347900
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
1,315
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,586.70 | 15.30 | 0.18% |
CAC 40 | 7,734.40 | 130.04 | -1.65% |
DAX 40 | 23,629.58 | 369.59 | -1.54% |
Dow JONES (US) | 41,603.07 | 256.02 | -0.61% |
FTSE 100 | 8,717.97 | 21.29 | -0.24% |
HKSE | 23,601.26 | 56.95 | 0.24% |
NASDAQ | 18,737.21 | 188.53 | -1.00% |
Nikkei 225 | 37,160.47 | 174.60 | 0.47% |
NZX 50 Index | 12,596.50 | 65.75 | -0.52% |
S&P 500 | 5,802.82 | 39.19 | -0.67% |
S&P/ASX 200 | 8,360.90 | 12.20 | 0.15% |
SSE Composite Index | 3,348.37 | 31.82 | -0.94% |